Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of de novo MDS

Leuk Lymphoma. 2020 Mar;61(3):728-731. doi: 10.1080/10428194.2019.1689394. Epub 2019 Nov 12.

Authors

Adam S Sperling^{1

2}, Matthew Leventhal², Christopher J Gibson¹, Benjamin L Ebert^{1

2}, David P Steensma¹

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Broad Institute of MIT and Harvard, Cambridge, MA, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Agent Orange
Humans
Leukemia, Myeloid, Acute*
Mutation
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / genetics

Substances

Agent Orange

Grants and funding